This suggests that passive immunization with tau antibodies is often a viable therapeutic goal and that the CSF standard of p-tau262/356 or on the microtubule binding area (MTBD) can function a useful biomarker of tau pathology to watch tau therapeutics in clinical trials.You’re also going to want to safeguard your laptop computer by using a lapt… Read More